+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)
This field is for validation purposes and should be left unchanged.

Archives

Loading Events

Risk Factors for Rapid Disease Progression of ADPKD

Risk Factors for Rapid Disease Progression of ADPKD

In this presentation rapid disease progression of autosomal dominant polycystic kidney disease (ADPKD) will be defined. The risk factors that assist in determining if a patient is at risk of rapid disease progression will be discussed.    

Location

Pappas Seafood House

19991 I-45
Webster, TX 77598 United States
+ Google Map
(281) 332-7546 View Venue Website

Featuring

Biruh T Workeneh

Biruh T Workeneh, MD, FASN

Associate Professor, Department of Emergency Medicine, Division of Internal Medicine

The University of Texas MD Anderson Cancer Center*

Dr Biruh Workeneh is a provider in the MD Anderson Internal Medicine Center and an Associate Professor in the Section of Nephrology. He is board-certified in Internal Medicine and joined MD Anderson in 2015.

Molly Jansen

Molly Jansen, PhD

Nephrology Senior Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Dr Molly Jansen is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. covering South Texas. Molly earned her Doctor of Philosophy degree in Biomedical Science from Wake Forest School of Medicine located in Winston-Salem, NC. While in graduate school, Molly worked as a Business Development Intern at Wake Forest Innovations, fostering the collaborative innovation between industry and the faculty and staff of Wake Forest Baptist Medical Center. After graduate school, Molly did a brief Medical Writing Fellowship with Impact Pharmaceutical Services. Prior to joining Otsuka, Molly worked at Reata Pharmaceuticals, Inc. where she helped to oversee the conduct of clinical trials across a variety of therapeutic areas including nephrology, neurology, and pulmonary, which is where she developed her passion for rare disease.

*Dr Biruh Workeneh is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Molly Jansen is an employee of OPDC.

Registration

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.